Association of HIV-1 Envelope-Specific Breast Milk IgA Responses with Reduced Risk of Postnatal Mother-to-Child Transmission of HIV-1

ABSTRACT Infants born to HIV-1-infected mothers in resource-limited areas where replacement feeding is unsafe and impractical are repeatedly exposed to HIV-1 throughout breastfeeding. Despite this, the majority of infants do not contract HIV-1 postnatally, even in the absence of maternal antiretroviral therapy. This suggests that immune factors in breast milk of HIV-1-infected mothers help to limit vertical transmission. We compared the HIV-1 envelope-specific breast milk and plasma antibody responses of clade C HIV-1-infected postnatally transmitting and nontransmitting mothers in the control arm of the Malawi-based Breastfeeding Antiretrovirals and Nutrition Study using multivariable logistic regression modeling. We found no association between milk or plasma neutralization activity, antibody-dependent cell-mediated cytotoxicity, or HIV-1 envelope-specific IgG responses and postnatal transmission risk. While the envelope-specific breast milk and plasma IgA responses also did not reach significance in predicting postnatal transmission risk in the primary model after correction for multiple comparisons, subsequent exploratory analysis using two distinct assay methodologies demonstrated that the magnitudes of breast milk total and secretory IgA responses against a consensus HIV-1 envelope gp140 (B.con env03) were associated with reduced postnatal transmission risk. These results suggest a protective role for mucosal HIV-1 envelope-specific IgA responses in the context of postnatal virus transmission. This finding supports further investigations into the mechanisms by which mucosal IgA reduces risk of HIV-1 transmission via breast milk and into immune interventions aimed at enhancing this response. IMPORTANCE Infants born to HIV-1-infected mothers are repeatedly exposed to the virus in breast milk. Remarkably, the transmission rate is low, suggesting that immune factors in the breast milk of HIV-1-infected mothers help to limit transmission. We compared the antibody responses in plasma and breast milk of HIV-1-transmitting and -nontransmitting mothers to identify responses that correlated with reduced risk of postnatal HIV-1 transmission. We found that neither plasma nor breast milk IgG antibody responses were associated with risk of HIV-1 transmission. In contrast, the magnitudes of the breast milk IgA and secretory IgA responses against HIV-1 envelope proteins were associated with reduced risk of postnatal HIV-1 transmission. The results of this study support further investigations of the mechanisms by which mucosal IgA may reduce the risk of HIV-1 transmission via breastfeeding and the development of strategies to enhance milk envelope-specific IgA responses to reduce mother-to-child HIV transmission and promote an HIV-free generation.

[1]  J. Overbaugh,et al.  Passively acquired antibody-dependent cellular cytotoxicity (ADCC) activity in HIV-infected infants is associated with reduced mortality. , 2015, Cell host & microbe.

[2]  J. Overbaugh,et al.  The role of cell-associated virus in mother-to-child HIV transmission. , 2014, The Journal of infectious diseases.

[3]  J. Overbaugh Mother–Infant HIV Transmission: Do Maternal HIV-Specific Antibodies Protect the Infant? , 2014, PLoS pathogens.

[4]  Allan C. deCamp,et al.  Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection , 2014, PloS one.

[5]  H. Erickson,et al.  Tenascin-C is an innate broad-spectrum, HIV-1–neutralizing protein in breast milk , 2013, Proceedings of the National Academy of Sciences.

[6]  Raphael Gottardo,et al.  Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial , 2013, PloS one.

[7]  T. Hope,et al.  New paradigms for functional HIV-specific nonneutralizing antibodies. , 2013, Current opinion in HIV and AIDS.

[8]  B. Corthésy,et al.  Multi-Faceted Functions of Secretory IgA at Mucosal Surfaces , 2013, Front. Immunol..

[9]  Jerome H. Kim,et al.  Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG , 2013, Proceedings of the National Academy of Sciences.

[10]  Haiyan Chen,et al.  Mucosal Immunization of Lactating Female Rhesus Monkeys with a Transmitted/Founder HIV-1 Envelope Induces Strong Env-Specific IgA Antibody Responses in Breast Milk , 2013, Journal of Virology.

[11]  A. Lapedes,et al.  Antigenicity and Immunogenicity of Transmitted/Founder, Consensus, and Chronic Envelope Glycoproteins of Human Immunodeficiency Virus Type 1 , 2013, Journal of Virology.

[12]  Guido Ferrari,et al.  Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2. , 2013, Immunity.

[13]  G. Learn,et al.  Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants , 2013, Retrovirology.

[14]  Jerome H. Kim,et al.  The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120. , 2012, AIDS research and human retroviruses.

[15]  Tomer Hertz,et al.  Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env-V2 , 2012, Nature.

[16]  Jerome H. Kim,et al.  Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family , 2012, Journal of Virology.

[17]  J. Overbaugh,et al.  HIV-Specific Antibodies Capable of ADCC Are Common in Breastmilk and Are Associated with Reduced Risk of Transmission in Women with High Viral Loads , 2012, PLoS pathogens.

[18]  Guido Ferrari,et al.  Immune-correlates analysis of an HIV-1 vaccine efficacy trial. , 2012, The New England journal of medicine.

[19]  J. Kappes,et al.  High‐throughput quantitative analysis of HIV‐1 and SIV‐specific ADCC‐mediating antibody responses , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[20]  B. Haynes,et al.  HIV-Specific Functional Antibody Responses in Breast Milk Mirror Those in Plasma and Are Primarily Mediated by IgG Antibodies , 2011, Journal of Virology.

[21]  H. Ding,et al.  Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC. , 2010, Virology.

[22]  Michael G Hudgens,et al.  Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. , 2010, The New England journal of medicine.

[23]  M. Clerici,et al.  Hiv-specific secretory IgA in breast milk of HIV-positive mothers is not associated with protection against HIV transmission among breast-fed infants. , 2006, The Journal of pediatrics.

[24]  Feng Gao,et al.  A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses. , 2006, Virology.

[25]  S. Challacombe,et al.  Comparison of Human Immunodeficiency Virus Type 1-Specific Inhibitory Activities in Saliva and Other Human Mucosal Fluids , 2006, Clinical and Vaccine Immunology.

[26]  J. Binley,et al.  Nature of Nonfunctional Envelope Proteins on the Surface of Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.

[27]  B. Shacklett Understanding the "lucky few": The conundrum of HIV-exposed, seronegative individuals , 2006, Current HIV/AIDS reports.

[28]  Bette T. Korber,et al.  Antigenicity and Immunogenicity of a Synthetic Human Immunodeficiency Virus Type 1 Group M Consensus Envelope Glycoprotein , 2005, Journal of Virology.

[29]  D. Montefiori,et al.  Evaluating Neutralizing Antibodies Against HIV, SIV, and SHIV in Luciferase Reporter Gene Assays , 2004, Current protocols in immunology.

[30]  W. Fawzi,et al.  Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. , 2004, The Journal of infectious diseases.

[31]  M. Newell,et al.  Breast-feeding and Transmission of HIV-1. , 2004, Journal of acquired immune deficiency syndromes.

[32]  B. Strandvik,et al.  The Transfer of Immunity from Mother to Child , 2003, Annals of the New York Academy of Sciences.

[33]  F. X. Lü,et al.  Predominate HIV1-specific IgG activity in various mucosal compartments of HIV1-infected individuals. , 2000, Clinical immunology.

[34]  F. Onyango,et al.  Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. , 2000, JAMA.

[35]  C. G. Victoria,et al.  Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis , 2000, The Lancet.

[36]  M. Kazatchkine,et al.  Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV. , 2000, The Journal of infectious diseases.

[37]  A. Trkola,et al.  A Cell Line-Based Neutralization Assay for Primary Human Immunodeficiency Virus Type 1 Isolates That Use either the CCR5 or the CXCR4 Coreceptor , 1999, Journal of Virology.

[38]  A. Pinter,et al.  Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1/V2 domain of HIV-1 gp120. , 1998, Vaccine.

[39]  D. Roos,et al.  FcγRIIIa-158V/F Polymorphism Influences the Binding of IgG by Natural Killer Cell FcγRIIIa, Independently of the FcγRIIIa-48L/R/H Phenotype , 1997 .

[40]  K. Holmes,et al.  Human immunodeficiency virus type 1 IgA antibody in breast milk and serum. , 1994, The Pediatric infectious disease journal.

[41]  S. Ahlstedt,et al.  The immune response of the mammary gland and its significance for the neonate. , 1984, Annals of allergy.

[42]  L. Morris,et al.  The Antibody Response against HIV-1. , 2012, Cold Spring Harbor perspectives in medicine.

[43]  P. Van de Perre Transfer of antibody via mother's milk. , 2003, Vaccine.

[44]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .